Hepatitis B News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

US panel recommends new adult vaccine against hepatitis B - ABC News



UPI.com
 
US panel recommends new adult vaccine against hepatitis B 
ABC News
The new vaccine made by Dynavax Technologies Corp. is for adults and uses an additive that boosts the body's immune response. It is given in two shots over a month. Experts hope that will improve vaccination rates, because other vaccines are given in a ...
ACIP Recommends Use of Heplisav-B for Hepatitis B Prevention in Adults Monthly Prescribing Reference
Dynavax stock rises after hepatitis B vaccine recommendation by CDC immunization committee MarketWatch
CDC panel approves new hepatitis B vaccine for adults UPI.com
GlobeNewswire (press release) 
all 13 news articles » 


Drug Attacks Hepatitis B Virus Capsid - Specialty Pharmacy Times



Drug Attacks Hepatitis B Virus Capsid 
Specialty Pharmacy Times
Researchers have recently made progress in developing new drugs to combat hepatitis B virus (HBV), according to a new study published by eLife. Billions of individuals worldwide have been infected with HBV and millions are living with a chronic ...

 


New Jersey Health Foundation grants $50k to hepatitis B, E research - Healio



Infectious Disease Advisor
 
New Jersey Health Foundation grants $50k to hepatitis B, E research 
Healio
The New Jersey Health Foundation awarded a $50000 Innovation Grant to Alexander Ploss, PhD, assistant professor of molecular biology at Princeton University, for hepatitis B and hepatitis E treatment research, according to a press release. ?Fortunately ...
Rate of Hepatitis B Reactivation During DAA Therapy for Hepatitis C ... Infectious Disease Advisor

all 2 news articles » 


Hepatitis B Infects Organ-on-a-Chip Platform - Genetic Engineering & Biotechnology News



Genetic Engineering & Biotechnology News
 
Hepatitis B Infects Organ-on-a-Chip Platform 
Genetic Engineering & Biotechnology News
For the first time, a real pathogen has instigated a real disease process in an artificial organ, and scientists are really, really pleased. As far as scientists are concerned, the whole point of an artificial organ?in this case, a liver-on-a-chip ...
Organ-on-chip technology enters next stage as experts test hepatitis B virus Science Daily
Organ-on-chip technology revels hepatitis B virus interactions with ... Clinical Innovation + Technology
Organ-on-chip technology enters the next stage as specialists test ... Tech Explorist (press release)
MedicalResearch.com (blog)  -Electronics360 
all 7 news articles » 


Organ-on-a-Chip Technology Used to Spot New Hepatitis B Drug Targets - Labiotech.eu (blog)



Labiotech.eu (blog)
 
Organ-on-a-Chip Technology Used to Spot New Hepatitis B Drug Targets 
Labiotech.eu (blog)
Scientists in London are the first in the world to test how pathogens like the hepatitis B virus interact with artificial human organs. Researchers at Imperial College London have used artificial human organs, or organs-on-chips, to replicate the make ...

 


Xconomy: Arrowhead Plans Return to Clinic With New Study of Hep ... - Xconomy



Xconomy
 
Xconomy: Arrowhead Plans Return to Clinic With New Study of Hep ... 
Xconomy
On Thursday, Pasadena, CA-based Arrowhead?which houses its research and development operations in Madison, WI?said regulators cleared the company to initiate a clinical study of a drug it's developing to treat chronic hepatitis B virus. Arrowhead ...

and more » 


Global Hepatitis B Virus [HBV] Treatment Market Growth and Forecast to 2022 - Markets Insider



Digital Journal
 
Global Hepatitis B Virus [HBV] Treatment Market Growth and Forecast to 2022 
Markets Insider
PUNE, India, Feb. 20, 2018 /PRNewswire-iReach/ -- Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (N ...
Global Hepatitis B Virus Treatment Market Primary and Secondary ... Digital Journal

all 7 news articles » 


'Virus-cracking' molecules advance fight against hepatitis B ... - Science Daily



Science Daily
 
'Virus-cracking' molecules advance fight against hepatitis B ... 
Science Daily
Researchers have found that certain molecules -- currently under clinical trial -- are able to 'crack' the protective shell of the hepatitis B virus, suggesting it may be possible to attack the virus after its already taken hold in the body. There is ...

and more » 


Dynavax Secures $175 Million in Non-Dilutive Debt Financing - GlobeNewswire (press release)



Dynavax Secures $175 Million in Non-Dilutive Debt Financing 
GlobeNewswire (press release)
HEPLISAV-B was approved by the U.S. Food and Drug Administration (FDA) in November 2017 for the prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax commercially launched HEPLISAV-B in the ...

and more » 


Study reveals the liver's 'weak spot' for hepatitis B virus replication - Medical Xpress



Study reveals the liver's 'weak spot' for hepatitis B virus replication 
Medical Xpress
In the absence of protective proteins Slug and SOX7, hepatitis B infection thrives in liver cells, indicated by green staining in this image. Credit: A*STAR Singapore Immunology Network. In a surprising discovery, researchers from the Singapore ...